WallStSmart

Coursera Inc (COUR)vsCovista Inc. (CVSA)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 121% more annual revenue ($1.95B vs $885.40M). CVSA leads profitability with a 12.9% profit margin vs -15.4%. CVSA earns a higher WallStSmart Score of 71/100 (B).

COUR

Hold

43

out of 100

Grade: D

Growth: 7.3Profit: 2.0Value: 6.7Quality: 6.5
Piotroski: 5/9Altman Z: 1.03

CVSA

Strong Buy

71

out of 100

Grade: B

Growth: 8.0Profit: 7.5Value: 7.0Quality: 6.0
Piotroski: 4/9Altman Z: 3.06
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

COURUndervalued (+38.4%)

Margin of Safety

+38.4%

Fair Value

$9.32

Current Price

$3.71

$5.61 discount

UndervaluedFair: $9.32Overvalued

Intrinsic value data unavailable for CVSA.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COUR3 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
59.6%10/10

Revenue surging 59.6% year-over-year

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

CVSA5 strengths · Avg: 8.4/10
Altman Z-ScoreHealth
3.0610/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.938/10

Growing faster than its price suggests

P/E RatioValuation
17.6x8/10

Attractively priced relative to earnings

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

EPS GrowthGrowth
43.2%8/10

Earnings expanding 43.2% YoY

Areas to Watch

COUR4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$993.66M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-11.7%2/10

ROE of -11.7% — below average capital efficiency

Free Cash FlowQuality
$-20.10M2/10

Negative free cash flow — burning cash

CVSA0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : COUR

The strongest argument for COUR centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 59.6% demonstrates continued momentum.

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio, P/E Ratio. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bear Case : COUR

The primary concerns for COUR are EPS Growth, Market Cap, Return on Equity.

Bear Case : CVSA

No major red flags identified for CVSA, but monitor valuation.

Key Dynamics to Monitor

COUR profiles as a hypergrowth stock while CVSA is a value play — different risk/reward profiles.

COUR carries more volatility with a beta of 1.25 — expect wider price swings.

COUR is growing revenue faster at 59.6% — sustainability is the question.

CVSA generates stronger free cash flow (76M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (71/100 vs 43/100). COUR offers better value entry with a 38.4% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coursera Inc

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Coursera, Inc. operates an online educational content platform that connects students, educators, and institutions. The company is headquartered in Mountain View, California.

Visit Website →

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Want to dig deeper into these stocks?